What does an MHRA licence mean for our customers?
The MHRA supports innovation through scientific research and development. Part of the MHRA’s responsibility is ensuring that the supply chain for medicines, medical devices and blood components is safe and secure. Cryoniss holds a Wholesale Distribution Authority (Human) licence enabling it to store and coordinate the logistics of human Medicinal Products.
Cryoniss is compliant with the following regulations:
- EC guidelines for GDP of Medicinal Products for Human Use.
- Directive 2001/83/EC Community Code relating to Medicinal Products for Human Use.
- Regulations 43-45 of the Human Medicines Regulations 2012.
Using its state-of-the-art facilities and MHRA accredited Quality Management System, Cryoniss offers storage and end-to-end medicinal product supply chain solutions for customers, providing total assurance of the product integrity and supply chain security.
Cryoniss tailors the customer onboarding process to the customer and product, ensuring all Cryoniss personnel are aware of any critical control points of the new supply chain. These are methodically and thoroughly considered to enable the team to deliver the highest level of customer service and responsiveness, whilst ensuring the safety of patients receiving these products.